BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Deals

Molecular Partners, J&J deal

Johnson & Johnson's Janssen Biotech Inc. unit partnered with Molecular Partners to discover and develop multispecific designed ankyrin repeat proteins (DARPins) against undisclosed targets to treat immunological diseases. The partners will jointly conduct research and Janssen...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >